ConductScience.org, home

Trial · NCT00565812

Outcomes44

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYRate of Progression of Joint Space NarrowingBaseline up to Month 24FAS included all participants randomized to the study. Here, 'number of participants analyzed' (N) signifies participants evaluable for this outcome measure.mm/yearMEAN
PRIMARYRate of Progression of Joint Space Narrowing in Participants With Kellgren and Lawrence Grade Less Than or Equal to (<=) 2Baseline up to Month 24FAS included all participants randomized to the study. Here, 'N' signifies participants with KLG \<=2 and evaluable for this outcome measure.mm/yearMEAN
PRIMARYRate of Progression of Joint Space Narrowing in Participants With Kellgren and Lawrence Grade Equal to (=) 3Baseline up to Month 24FAS included all participants randomized to the study. Here, 'N' signifies participants with KLG =3 and evaluable for this outcome measure.mm/yearMEAN
SECONDARYChange From Baseline in Western Ontario and MacMaster Osteoarthritis Index (WOMAC) Composite Index Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Western Ontario and MacMaster Osteoarthritis Index Pain Subscale Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Western Ontario and MacMaster Osteoarthritis Index Pain Stiffness Subscale Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Western Ontario and MacMaster Osteoarthritis Index Physical Function Subscale Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Patient Assessment of Arthritic Pain Visual Analog Scale (VAS) Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.mmMEAN
SECONDARYChange From Baseline in Patient Global Assessment of Arthritic Condition Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Physician's Global Assessment of Arthritic Condition Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Pain After a 50-foot Walk Using Pain Visual Analog Scale Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Osteoarthritis Pain Assessment Tool-Knee Joint Total Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluated for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Osteoarthritis Pain Assessment Tool-Knee Joint Constant Pain Subscale Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Osteoarthritis Pain Assessment Tool-Knee Joint Intermittent Pain Subscale Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Osteoarthritis Research Society International (OARSI) Knee Function Survey Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Knee Injury and Osteoarthritis Outcome Score - Physical Function Short Form (KOOS-PS) Score at Month 3, 6, 12, 18 and 24Baseline, Month 3, 6, 12, 18, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Short Form-36 (SF-36) Physical Functioning Domain Score at Month 12 and 24Baseline, Month 12, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Short Form-36 Role - Physical Domain Score at Month 12 and 24Baseline, Month 12, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Short Form-36 Bodily Pain Domain Score at Month 12 and 24Baseline, Month 12, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN
SECONDARYChange From Baseline in Short Form-36 General Health Domain Score at Month 12 and 24Baseline, Month 12, 24FAS included all participants randomized to the study. Here, 'n' signifies participants evaluable for this outcome measure at given time points for each group.units on a scaleMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00565812/outcomes